GBS, a life sciences company, has been awarded $6.3 million under the federal government’s Medical Products Priority Grants to build a Biosensor manufacturing facility.
Read More
Australian medical manufacturing funded to upscale operations
Under the Modern Manufacturing Initiative (MMI), the federal government will invest over $36 million in five Australian medical manufacturing companies, to reduce reliance on overseas suppliers for vital medications.
Read More
Read More